2359.HK 603259.SHG

Pharmaceutical outsourcing giant WuXi AppTec Co. Ltd. (2359.HK; 603259.SH) announced on Thursday it will raise HK$7.65 billion ($975 million) by placing around 73.8 million new Hong Kong-listed shares at HK$104.27 per share, representing a 6.9% discount to the stock’s previous closing price of HK$112. The new shares account for about 16.01% of the company’s enlarged capital for its Hong Kong-listed stock and 2.51% of its total issued share capital.

WuXi AppTec said around 90% of the proceeds will be used to accelerate expansion of its global footprint and expand production capacity, while the remaining 10% will go toward general corporate purposes.

The share placement comes shortly after the company reported strong first-half results. Revenue for the six months through June rose 20.64% year-on-year to 20.8 billion yuan, while its net profit surged 95.46% to 8.29 billion yuan.

WuXi AppTec’s stock opened lower on Thursday and closed at HK$107.8 by the midday break, down 3.75%. The stock is up 90% year-to-date.

By Lee Shih Ta

To subscribe to Bamboo Works weekly free newsletter, click here

Recent Articles

Futu does stocks

Is Futu’s bull run nearing an end?

The brokerage’s stock has more than doubled since the start of the year, as it records strong revenue and profit growth fueled by heavy trading volumes Key Takeaways: Futu reported…